| Pharmaceutical active ingredients: |
| Abacavir Sulfate |
| Available forms, composition and doses of Abacavir: |
| Solution; Oral; Abacavir Sulfate 20 mg / mlTablets; Oral; Abacavir Sulfate 60 mgTablets; Oral; Abacavir Sulfate 300 mg |
| Abacavir medical category: |
| Human:Nucleoside and nucleotide reverse transcriptase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AF06 - Abacavir |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Cipla |